Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multi-center Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adults and Compare to the Safety and Immune Response of a Licensed Conjugate Meningococcal ACWY Vaccine in Subjects Aged 19-55 Years of Age and to a Licensed Polysaccharide Vaccine in Subjects Aged 56-65 Years of Age.

NCT00474487 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT00474487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00474487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multi-center Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adults and Compare to the Safety and Immune Response of a Licensed Conjugate Meningococcal ACWY Vaccine in Subjects Aged 19-55 Years of Age and to a Licensed Polysaccharide Vaccine in Subjects Aged 56-65 Years of Age.
Lead sponsor
Novartis Vaccines
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2007
Completion date
February 29, 2008
Enrollment
2,831 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal infections, meningococcal meningitis